Cargando…
Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs
A considerable number of drugs were withdrawn from the world market in the last decades due to safety reasons. A retrospective review of withdrawals is important in determining the adequacy of regulations regarding the safety and efficacy of drugs. The scope of the present study was to focus on card...
Autores principales: | Kocadal, Kumsal, Saygi, Sahan, Alkas, Fehmi Burak, Sardas, Semra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593908/ https://www.ncbi.nlm.nih.gov/pubmed/31297490 http://dx.doi.org/10.14744/nci.2018.44977 |
Ejemplares similares
-
WITHDRAWN—a resource for withdrawn and discontinued drugs
por: Siramshetty, Vishal B., et al.
Publicado: (2016) -
A comparative analysis of protein targets of withdrawn cardiovascular drugs in human and mouse
por: Zhao, Yuqi, et al.
Publicado: (2012) -
WITHDRAWN: COVID-19 Emergency Responders in FDA’s Center for Drug Evaluation and Research
por: Gormley, LCDR Andrea, et al.
Publicado: (2020) -
Drug safety: withdrawn medications are only part of the picture
por: Rawson, Nigel S. B.
Publicado: (2016) -
Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn
Drugs
por: Hunter, Fiona M.I., et al.
Publicado: (2021)